Cargando…
Analysis of quality of life after randomized controlled trial of alpha-1 adrenoceptor antagonist alone and in combination with cyclooxygenase-2 inhibitor in patients who underwent low-dose-rate brachytherapy for prostate cancer
PURPOSE: The goal of this study was to evaluate the effect of cyclooxygenase-2 (COX-2) inhibitors on quality of life (QoL) of patients undergoing low-dose-rate (LDR) brachytherapy. MATERIAL AND METHODS: A total of 310 patients with prostate cancer who had undergone LDR brachytherapy were enrolled. T...
Autores principales: | Nakai, Yasushi, Tanaka, Nobumichi, Asakawa, Isao, Torimoto, Kazumasa, Miyake, Makito, Anai, Satoshi, Fujii, Tomomi, Hasegawa, Masatoshi, Fujimoto, Kiyohide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854856/ https://www.ncbi.nlm.nih.gov/pubmed/31749848 http://dx.doi.org/10.5114/jcb.2019.88142 |
Ejemplares similares
-
Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil -
por: Tanaka, Nobumichi, et al.
Publicado: (2014) -
Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer
por: Tanaka, Nobumichi, et al.
Publicado: (2017) -
Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer
por: Onishi, Kenta, et al.
Publicado: (2018) -
Quality of life in patients who underwent (125)I brachytherapy, (125)I brachytherapy combined with three-dimensional conformal radiation therapy, or intensity-modulated radiation therapy, for prostate cancer
por: Nakai, Yasushi, et al.
Publicado: (2019) -
Quality of life worsened the most severely in patients immediately after intensity-modulated radiotherapy for prostate cancer
por: Nakai, Yasushi, et al.
Publicado: (2018)